{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:59:44Z","timestamp":1780631984408,"version":"3.54.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.radonc.2008.09.007","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T04:11:40Z","timestamp":1225426300000},"page":"166-171","source":"Crossref","is-referenced-by-count":130,"title":["High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes"],"prefix":"10.1016","volume":"90","author":[{"given":"Christian","family":"Giro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"B\u00f6lke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Frank","family":"Ciernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Duprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Locati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Ozsahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Gerry","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2008.09.007_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2008.09.007_bib2","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2008.09.007_bib3","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMc076359","article-title":"More on severe cutaneous reaction with radiotherapy and cetuximab","volume":"357","author":"Bonner","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2008.09.007_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clon.2007.09.003","article-title":"Cetuximab is effective, but more toxic than reported in the Bonner Trial","volume":"20","author":"Lord","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2008.09.007_bib5","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2008.09.007_bib6","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1200\/JCO.2007.11.8984","article-title":"Biology of interactions: antiepidermal growth factor receptor agents","volume":"25","author":"Harari","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2008.09.007_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(01)00358-9","article-title":"Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial","volume":"60","author":"Bentzen","year":"2001","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2008.09.007_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(97)00094-7","article-title":"A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer","volume":"44","author":"Dische","year":"1997","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2008.09.007_bib9","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1200\/JCO.2005.04.9148","article-title":"Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of radiation therapy oncology group trial 99\u201313","volume":"24","author":"Elliott","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2008.09.007_bib10","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.5301\/JBM.2008.4642","article-title":"Treatment of advanced head and neck cancer with cetuximab","volume":"22","author":"Merlano","year":"2007","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.radonc.2008.09.007_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1748-717X-3-5","article-title":"Severe skin reaction secondary to concomitant radiotherapy plus cetuximab","volume":"3","author":"Berger","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2008.09.007_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/annonc\/mdm400","article-title":"Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck","volume":"19","author":"Bernier","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2008.09.007_bib13","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1091\/mbc.01-12-0572","article-title":"Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells","volume":"13","author":"Amorino","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.radonc.2008.09.007_bib14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2008.09.007_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00066-007-1696-z","article-title":"Combination of EGFR\/HER2 tyrosine kinase inhibition by BIBW 2992 and BIBW 2669 with irradiation in FaDu human squamous cell carcinoma","volume":"183","author":"Schutze","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2008.09.007_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0002-9440(10)63654-1","article-title":"Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation","volume":"163","author":"Mascia","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.radonc.2008.09.007_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cbir.1994.1001","article-title":"The role of growth factors in gastrointestinal cell proliferation","volume":"18","author":"Alison","year":"1994","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.radonc.2008.09.007_bib18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/095530098142536","article-title":"Bowman\u2013Birk protease inhibitor reduces the radiation-induced activation of the EGF receptor and induces tyrosine phosphatase activity","volume":"73","author":"Gueven","year":"1998","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2008.09.007_bib19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/09553000500168515","article-title":"Effect of EGFR-inhibition on the radiation response of oral mucosa: experimental studies in mouse tongue epithelium","volume":"81","author":"Fehrmann","year":"2005","journal-title":"Int J Radiat Biol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814008004933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814008004933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T14:52:29Z","timestamp":1545663149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814008004933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0167814008004933"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2008.09.007","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}